4//SEC Filing
Rey Eric J. 4
Accession 0001209191-18-020441
CIK 0001469443other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 8:11 PM ET
Size
14.3 KB
Accession
0001209191-18-020441
Insider Transaction Report
Form 4
Rey Eric J.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2018-03-15−250→ 35,719 totalExercise: $44.88Exp: 2019-11-01→ Common Stock (250 underlying) - Sale
Common Stock
2018-03-15$60.00/sh−250$15,000→ 7,335 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-03-14−21,005→ 35,969 totalExercise: $21.60Exp: 2018-06-30→ Common Stock (21,005 underlying) - Exercise/Conversion
Common Stock
2018-03-14$21.60/sh+21,005$453,708→ 28,340 total - Sale
Common Stock
2018-03-14$45.21/sh−21,005$949,615→ 7,335 total - Exercise/Conversion
Common Stock
2018-03-15$44.80/sh+250$11,200→ 7,585 total
Footnotes (3)
- [F1]The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 6, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $38.00 to $49.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The option is fully exercisable as of the date hereof.
Documents
Issuer
Arcadia Biosciences, Inc.
CIK 0001469443
Entity typeother
Related Parties
1- filerCIK 0001640665
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 8:11 PM ET
- Size
- 14.3 KB